View ValuationThis company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsCNP Assurances 将来の成長Future 基準チェック /26主要情報5.7%収益成長率6.32%EPS成長率Insurance 収益成長5.6%収益成長率8.5%将来の株主資本利益率7.99%アナリストカバレッジLow最終更新日n/a今後の成長に関する最新情報Price Target Changed • Apr 27Price target increased to €21.80Up from €19.56, the current price target is an average from 4 analysts. New target price is approximately in line with last closing price of €20.90. Stock is up 43% over the past year. The company is forecast to post earnings per share of €2.20 for next year compared to €2.20 last year.Price Target Changed • Nov 25Price target increased to €21.37Up from €19.56, the current price target is an average from 6 analysts. New target price is approximately in line with last closing price of €21.60. Stock is up 60% over the past year. The company is forecast to post earnings per share of €2.08 for next year compared to €1.91 last year.Price Target Changed • Nov 22Price target increased to €20.42Up from €18.36, the current price target is an average from 6 analysts. New target price is 5.3% below last closing price of €21.57. Stock is up 63% over the past year. The company is forecast to post earnings per share of €2.07 for next year compared to €1.91 last year.Price Target Changed • Oct 29Price target increased to €20.11Up from €18.36, the current price target is an average from 6 analysts. New target price is 7.2% below last closing price of €21.66. Stock is up 124% over the past year. The company is forecast to post earnings per share of €2.01 for next year compared to €1.91 last year.Price Target Changed • Mar 10Price target raised to €17.37Up from €15.79, the current price target is an average from 7 analysts. The new target price is 5.8% above the current share price of €16.42. As of last close, the stock is up 47% over the past year.Price Target Changed • Jan 08Price target raised to €15.79Up from €14.75, the current price target is an average from 7 analysts. The new target price is 15% above the current share price of €13.70. As of last close, the stock is down 21% over the past year.すべての更新を表示Recent updatesReported Earnings • May 14First quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behindFirst quarter 2022 results: EPS: €0.56. Revenue: €10.2b (up 26% from 1Q 2021). Net income: €381.0m (up 24% from 1Q 2021). Profit margin: 3.7% (down from 3.8% in 1Q 2021). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 1.3%. Earnings per share (EPS) exceeded analyst estimates by 2.6%. Over the next year, revenue is expected to shrink by 26% compared to a 14% growth forecast for the industry in France. Over the last 3 years on average, earnings per share has increased by 6% per year whereas the company’s share price has increased by 1% per year.Price Target Changed • Apr 27Price target increased to €21.80Up from €19.56, the current price target is an average from 4 analysts. New target price is approximately in line with last closing price of €20.90. Stock is up 43% over the past year. The company is forecast to post earnings per share of €2.20 for next year compared to €2.20 last year.Upcoming Dividend • Apr 20Upcoming dividend of €1.00 per shareEligible shareholders must have bought the stock before 27 April 2022. Payment date: 29 April 2022. Payout ratio is a comfortable 46% and this is well supported by cash flows. Trailing yield: 4.6%. Lower than top quartile of French dividend payers (4.8%). In line with average of industry peers (5.0%).Reported Earnings • Feb 18Full year 2021 earnings: Revenues miss analyst expectationsFull year 2021 results: Revenue: €32.5b (down 6.5% from FY 2020). Net income: €1.55b (up 19% from FY 2020). Profit margin: 4.8% (up from 3.8% in FY 2020). The increase in margin was driven by lower expenses. Revenue missed analyst estimates by 1.3%. Over the next year, revenue is forecast to grow 3.1%, compared to a 81% growth forecast for the insurance industry in France. Over the last 3 years on average, earnings per share has increased by 2% per year whereas the company’s share price has increased by 3% per year.Price Target Changed • Nov 25Price target increased to €21.37Up from €19.56, the current price target is an average from 6 analysts. New target price is approximately in line with last closing price of €21.60. Stock is up 60% over the past year. The company is forecast to post earnings per share of €2.08 for next year compared to €1.91 last year.Price Target Changed • Nov 22Price target increased to €20.42Up from €18.36, the current price target is an average from 6 analysts. New target price is 5.3% below last closing price of €21.57. Stock is up 63% over the past year. The company is forecast to post earnings per share of €2.07 for next year compared to €1.91 last year.Reported Earnings • Nov 20Third quarter 2021 earnings released: EPS €0.50The company reported a decent third quarter result with improved earnings and profit margins, although revenues were weaker. Third quarter 2021 results: Revenue: €462.6m (down 93% from 3Q 2020). Net income: €341.3m (up 10% from 3Q 2020). Profit margin: 74% (up from 4.8% in 3Q 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 2% per year whereas the company’s share price has increased by 3% per year.Price Target Changed • Oct 29Price target increased to €20.11Up from €18.36, the current price target is an average from 6 analysts. New target price is 7.2% below last closing price of €21.66. Stock is up 124% over the past year. The company is forecast to post earnings per share of €2.01 for next year compared to €1.91 last year.Valuation Update With 7 Day Price Move • Oct 28Investor sentiment improved over the past weekAfter last week's 48% share price gain to €21.70, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 11x in the Insurance industry in Europe. Total returns to shareholders of 27% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €29.90 per share.Reported Earnings • Aug 02Second quarter 2021 earnings releasedThe company reported a solid second quarter result with improved earnings and revenues, although profit margins were weaker. Second quarter 2021 results: Revenue: €8.20b (up 47% from 2Q 2020). Net income: €382.0m (up 24% from 2Q 2020). Profit margin: 4.7% (down from 5.5% in 2Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings.Reported Earnings • May 16First quarter 2021 earnings released: EPS €0.45The company reported a solid first quarter result with improved earnings and revenues, although profit margins were weaker. First quarter 2021 results: Revenue: €8.08b (up 16% from 1Q 2020). Net income: €308.0m (up 3.0% from 1Q 2020). Profit margin: 3.8% (down from 4.3% in 1Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 1% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings.Executive Departure • Apr 19Chief Executive Officer Antoine Lissowski has left the companyOn the 16th of April, Antoine Lissowski's tenure as Chief Executive Officer of the company ended after 2.6 years in the role. As of December 2020, Antoine personally held only 2.00k shares (€26k worth at the time). A total of 4 executives have left over the last 12 months. Under Antoine's leadership, the company delivered a total shareholder return of -12%.Upcoming Dividend • Apr 14Upcoming dividend of €1.57 per shareEligible shareholders must have bought the stock before 21 April 2021. Payment date: 23 April 2021. Trailing yield: 4.7%. Within top quartile of French dividend payers (4.0%). In line with average of industry peers (4.6%).Reported Earnings • Mar 18Full year 2020 earnings released: EPS €1.91 (vs €1.99 in FY 2019)The company reported a soft full year result with weaker earnings and revenues, although profit margins were improved. Full year 2020 results: Revenue: €34.8b (down 28% from FY 2019). Net income: €1.31b (down 4.0% from FY 2019). Profit margin: 3.8% (up from 2.8% in FY 2019). The increase in margin was driven by lower expenses. Combined ratio: 82.1% (up from 81.0% in FY 2019). Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has fallen by 7% per year, which means it is significantly lagging earnings.Price Target Changed • Mar 10Price target raised to €17.37Up from €15.79, the current price target is an average from 7 analysts. The new target price is 5.8% above the current share price of €16.42. As of last close, the stock is up 47% over the past year.Is New 90 Day High Low • Feb 15New 90-day high: €13.92The company is up 12% from its price of €12.46 on 17 November 2020. The French market is up 5.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Insurance industry, which is up 3.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €22.96 per share.Price Target Changed • Jan 08Price target raised to €15.79Up from €14.75, the current price target is an average from 7 analysts. The new target price is 15% above the current share price of €13.70. As of last close, the stock is down 21% over the past year.Is New 90 Day High Low • Jan 06New 90-day high: €13.88The company is up 27% from its price of €10.92 on 08 October 2020. The French market is up 14% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Insurance industry, which is up 21% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €23.79 per share.Reported Earnings • Nov 25Third quarter 2020 earnings released: EPS €0.45The company reported a decent third quarter result with improved revenues, although earnings and profit margins were weaker. Third quarter 2020 results: Revenue: €6.48b (up €5.41b from 3Q 2019). Net income: €310.0m (down 5.8% from 3Q 2019). Profit margin: 4.8% (down from 31% in 3Q 2019). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings.Valuation Update With 7 Day Price Move • Nov 10Market bids up stock over the past weekAfter last week's 19% share price gain to €11.72, the stock is trading at a trailing P/E ratio of 6.1x, up from the previous P/E ratio of 5.2x. This compares to an average P/E of 14x in the Insurance industry in France. Total return to shareholders over the past three years is a loss of 35%.Is New 90 Day High Low • Oct 27New 90-day low: €9.93The company is down 5.0% from its price of €10.48 on 29 July 2020. The French market is flat over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Insurance industry, which is down 14% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €17.27 per share.業績と収益の成長予測ENXTPA:CNP - アナリストの将来予測と過去の財務データ ( )EUR Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数12/31/202457,0931,755N/A23,633112/31/202351,4001,642N/A21,089112/31/202246,1281,587N/A26,10813/31/202246,0611,581N/AN/AN/A12/31/202143,9301,5089,1439,331N/A9/30/202139,6901,400N/AN/AN/A6/30/202145,8801,3697,0048,248N/A3/31/202135,6911,317N/AN/AN/A12/31/202034,7521,3084,5195,776N/A9/30/202041,8971,293N/AN/AN/A6/30/202035,7041,3122,1972,289N/A3/31/202047,1591,335N/AN/AN/A12/31/201948,5731,3628,8108,919N/A9/30/201939,8671,349N/AN/AN/A6/30/201942,0161,32611,31611,386N/A3/31/201938,4561,330N/AN/AN/A12/31/201838,5211,3177,9938,070N/A9/30/201845,7481,265N/AN/AN/A6/30/201843,0631,2525,2395,317N/A3/31/201845,7661,247N/AN/AN/A12/31/201745,0111,2364,0564,109N/A9/30/201741,6471,164N/AN/AN/A6/30/201745,2901,1624,0144,092N/A3/31/201740,9791,145N/AN/AN/A12/31/201642,4031,1248,2168,302N/A9/30/201644,3471,067N/AN/AN/A6/30/201640,6891,0617,6507,749N/A3/31/201644,2231,057N/AN/AN/A12/31/201543,5841,056N/A8,881N/A9/30/201544,4261,053N/AN/AN/A6/30/201544,8621,034N/A10,634N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: CNPの予測収益成長率 (年間5.7% ) は 貯蓄率 ( 0.3% ) を上回っています。収益対市場: CNPの収益 ( 5.7% ) French市場 ( 12.4% ) よりも低い成長が予測されています。高成長収益: CNPの収益は増加すると予測されていますが、大幅には増加しません。収益対市場: CNPの収益 ( 8.5% ) French市場 ( 5.7% ) よりも速いペースで成長すると予測されています。高い収益成長: CNPの収益 ( 8.5% ) 20%よりも低い成長が予測されています。一株当たり利益成長率予想将来の株主資本利益率将来のROE: CNPの 自己資本利益率 は、3年後には低くなると予測されています ( 8 %)。成長企業の発掘7D1Y7D1Y7D1YInsurance 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2022/06/20 07:27終値2022/06/14 00:00収益2022/03/31年間収益2021/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社の Github ページ でご覧いただけます。また、レポートの使い方に関する ガイド や YouTube の チュートリアル もご用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋CNP Assurances SA 2 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。13 アナリスト機関Andrew BroadfieldBarclaysMichael HuttnerBerenbergThomas JacquetBNP Paribas10 その他のアナリストを表示
Price Target Changed • Apr 27Price target increased to €21.80Up from €19.56, the current price target is an average from 4 analysts. New target price is approximately in line with last closing price of €20.90. Stock is up 43% over the past year. The company is forecast to post earnings per share of €2.20 for next year compared to €2.20 last year.
Price Target Changed • Nov 25Price target increased to €21.37Up from €19.56, the current price target is an average from 6 analysts. New target price is approximately in line with last closing price of €21.60. Stock is up 60% over the past year. The company is forecast to post earnings per share of €2.08 for next year compared to €1.91 last year.
Price Target Changed • Nov 22Price target increased to €20.42Up from €18.36, the current price target is an average from 6 analysts. New target price is 5.3% below last closing price of €21.57. Stock is up 63% over the past year. The company is forecast to post earnings per share of €2.07 for next year compared to €1.91 last year.
Price Target Changed • Oct 29Price target increased to €20.11Up from €18.36, the current price target is an average from 6 analysts. New target price is 7.2% below last closing price of €21.66. Stock is up 124% over the past year. The company is forecast to post earnings per share of €2.01 for next year compared to €1.91 last year.
Price Target Changed • Mar 10Price target raised to €17.37Up from €15.79, the current price target is an average from 7 analysts. The new target price is 5.8% above the current share price of €16.42. As of last close, the stock is up 47% over the past year.
Price Target Changed • Jan 08Price target raised to €15.79Up from €14.75, the current price target is an average from 7 analysts. The new target price is 15% above the current share price of €13.70. As of last close, the stock is down 21% over the past year.
Reported Earnings • May 14First quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behindFirst quarter 2022 results: EPS: €0.56. Revenue: €10.2b (up 26% from 1Q 2021). Net income: €381.0m (up 24% from 1Q 2021). Profit margin: 3.7% (down from 3.8% in 1Q 2021). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 1.3%. Earnings per share (EPS) exceeded analyst estimates by 2.6%. Over the next year, revenue is expected to shrink by 26% compared to a 14% growth forecast for the industry in France. Over the last 3 years on average, earnings per share has increased by 6% per year whereas the company’s share price has increased by 1% per year.
Price Target Changed • Apr 27Price target increased to €21.80Up from €19.56, the current price target is an average from 4 analysts. New target price is approximately in line with last closing price of €20.90. Stock is up 43% over the past year. The company is forecast to post earnings per share of €2.20 for next year compared to €2.20 last year.
Upcoming Dividend • Apr 20Upcoming dividend of €1.00 per shareEligible shareholders must have bought the stock before 27 April 2022. Payment date: 29 April 2022. Payout ratio is a comfortable 46% and this is well supported by cash flows. Trailing yield: 4.6%. Lower than top quartile of French dividend payers (4.8%). In line with average of industry peers (5.0%).
Reported Earnings • Feb 18Full year 2021 earnings: Revenues miss analyst expectationsFull year 2021 results: Revenue: €32.5b (down 6.5% from FY 2020). Net income: €1.55b (up 19% from FY 2020). Profit margin: 4.8% (up from 3.8% in FY 2020). The increase in margin was driven by lower expenses. Revenue missed analyst estimates by 1.3%. Over the next year, revenue is forecast to grow 3.1%, compared to a 81% growth forecast for the insurance industry in France. Over the last 3 years on average, earnings per share has increased by 2% per year whereas the company’s share price has increased by 3% per year.
Price Target Changed • Nov 25Price target increased to €21.37Up from €19.56, the current price target is an average from 6 analysts. New target price is approximately in line with last closing price of €21.60. Stock is up 60% over the past year. The company is forecast to post earnings per share of €2.08 for next year compared to €1.91 last year.
Price Target Changed • Nov 22Price target increased to €20.42Up from €18.36, the current price target is an average from 6 analysts. New target price is 5.3% below last closing price of €21.57. Stock is up 63% over the past year. The company is forecast to post earnings per share of €2.07 for next year compared to €1.91 last year.
Reported Earnings • Nov 20Third quarter 2021 earnings released: EPS €0.50The company reported a decent third quarter result with improved earnings and profit margins, although revenues were weaker. Third quarter 2021 results: Revenue: €462.6m (down 93% from 3Q 2020). Net income: €341.3m (up 10% from 3Q 2020). Profit margin: 74% (up from 4.8% in 3Q 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 2% per year whereas the company’s share price has increased by 3% per year.
Price Target Changed • Oct 29Price target increased to €20.11Up from €18.36, the current price target is an average from 6 analysts. New target price is 7.2% below last closing price of €21.66. Stock is up 124% over the past year. The company is forecast to post earnings per share of €2.01 for next year compared to €1.91 last year.
Valuation Update With 7 Day Price Move • Oct 28Investor sentiment improved over the past weekAfter last week's 48% share price gain to €21.70, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 11x in the Insurance industry in Europe. Total returns to shareholders of 27% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €29.90 per share.
Reported Earnings • Aug 02Second quarter 2021 earnings releasedThe company reported a solid second quarter result with improved earnings and revenues, although profit margins were weaker. Second quarter 2021 results: Revenue: €8.20b (up 47% from 2Q 2020). Net income: €382.0m (up 24% from 2Q 2020). Profit margin: 4.7% (down from 5.5% in 2Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings.
Reported Earnings • May 16First quarter 2021 earnings released: EPS €0.45The company reported a solid first quarter result with improved earnings and revenues, although profit margins were weaker. First quarter 2021 results: Revenue: €8.08b (up 16% from 1Q 2020). Net income: €308.0m (up 3.0% from 1Q 2020). Profit margin: 3.8% (down from 4.3% in 1Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 1% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings.
Executive Departure • Apr 19Chief Executive Officer Antoine Lissowski has left the companyOn the 16th of April, Antoine Lissowski's tenure as Chief Executive Officer of the company ended after 2.6 years in the role. As of December 2020, Antoine personally held only 2.00k shares (€26k worth at the time). A total of 4 executives have left over the last 12 months. Under Antoine's leadership, the company delivered a total shareholder return of -12%.
Upcoming Dividend • Apr 14Upcoming dividend of €1.57 per shareEligible shareholders must have bought the stock before 21 April 2021. Payment date: 23 April 2021. Trailing yield: 4.7%. Within top quartile of French dividend payers (4.0%). In line with average of industry peers (4.6%).
Reported Earnings • Mar 18Full year 2020 earnings released: EPS €1.91 (vs €1.99 in FY 2019)The company reported a soft full year result with weaker earnings and revenues, although profit margins were improved. Full year 2020 results: Revenue: €34.8b (down 28% from FY 2019). Net income: €1.31b (down 4.0% from FY 2019). Profit margin: 3.8% (up from 2.8% in FY 2019). The increase in margin was driven by lower expenses. Combined ratio: 82.1% (up from 81.0% in FY 2019). Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has fallen by 7% per year, which means it is significantly lagging earnings.
Price Target Changed • Mar 10Price target raised to €17.37Up from €15.79, the current price target is an average from 7 analysts. The new target price is 5.8% above the current share price of €16.42. As of last close, the stock is up 47% over the past year.
Is New 90 Day High Low • Feb 15New 90-day high: €13.92The company is up 12% from its price of €12.46 on 17 November 2020. The French market is up 5.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Insurance industry, which is up 3.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €22.96 per share.
Price Target Changed • Jan 08Price target raised to €15.79Up from €14.75, the current price target is an average from 7 analysts. The new target price is 15% above the current share price of €13.70. As of last close, the stock is down 21% over the past year.
Is New 90 Day High Low • Jan 06New 90-day high: €13.88The company is up 27% from its price of €10.92 on 08 October 2020. The French market is up 14% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Insurance industry, which is up 21% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €23.79 per share.
Reported Earnings • Nov 25Third quarter 2020 earnings released: EPS €0.45The company reported a decent third quarter result with improved revenues, although earnings and profit margins were weaker. Third quarter 2020 results: Revenue: €6.48b (up €5.41b from 3Q 2019). Net income: €310.0m (down 5.8% from 3Q 2019). Profit margin: 4.8% (down from 31% in 3Q 2019). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings.
Valuation Update With 7 Day Price Move • Nov 10Market bids up stock over the past weekAfter last week's 19% share price gain to €11.72, the stock is trading at a trailing P/E ratio of 6.1x, up from the previous P/E ratio of 5.2x. This compares to an average P/E of 14x in the Insurance industry in France. Total return to shareholders over the past three years is a loss of 35%.
Is New 90 Day High Low • Oct 27New 90-day low: €9.93The company is down 5.0% from its price of €10.48 on 29 July 2020. The French market is flat over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Insurance industry, which is down 14% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €17.27 per share.